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In June of 2003, McDonald’s Cor-poration announced that itwould prohibit its direct suppli-
ers from using antibiotics that are
important in human medicine as
growth promotants in food animals
after 2004. The company also cre-
ated a purchasing preference for
companies that work to minimize
antibiotic use. This announcement,
coupled with recent Food and Drug
Administration guidance on the
same issue, will put pressure on the
U.S. livestock industry to consider
alternatives to feed-grade antibiot-
ics. Denmark recently banned the
use of feed-grade antibiotics in pork
production and has been joined in
this action by countries in the Euro-
pean Union. We traveled to Den-
mark last summer to talk to Danish
veterinarians, farmers, economists,
and industry analysts about how
the ban was implemented and how
the Danish pork industry re-
sponded to the changes. What we
learned about the economic impact
of the ban, as well as the effects on
total antibiotic consumption, pro-
vides evidence of the likely eco-
nomic impacts of a similar ban for
the U.S. pork industry.
DENMARK’S VOLUNTARY BAN
Denmark’s pork industry is at least
as sophisticated as that of the
United States, with an export-ori-
ented and market-driven production
system. It is therefore a suitable
market for evaluating a ban on anti-
biotic growth promotants (AGPs).
The Danish government insti-
tuted a voluntary ban on the use of
AGPs in pork production at the fin-
ishing stage in 1998 (accompanied
by a penalty tax for use). On January
1, 2000, it banned AGPs at both the
weaning and finishing stages.
As shown in Figure 1 (based on
data from DANMAP 2001, published
by the Danish Veterinary Institute in
July 2002), Denmark’s total consump-
tion of antibiotics in pork production
was 152 metric tons (mt) of active
ingredient in 1996, 106 mt of AGPs,
and 48 mt of therapeutic use as medi-
cation. By 1998 when antibiotics were
banned from use at the finishing
stage, the total use was 106 mt. The
use of growth promotants fell by
about 50 percent (from 107 mt to 49
mt) and therapeutic use remained
about constant. By 1999, overall anti-
biotic use fell to a low of 74 mt.
The effective ban of AGPs at the
finishing stage in 1998 was accom-
plished through a tax and some
pressure to discontinue the use of
subtherapeutic antibiotics. Faced
with a tax of $2.00 per pig, most pro-
ducers stopped using the products
at the finishing stage.
Farmers reported very few
health problems in their herds, a re-
sult that indicates that most of the
benefits of AGP use at the finishing
stage were driven by a growth-pro-
moting effect plus a small reduction
in mortality. The Danes viewed the
ban at the finishing stage as a re-
sounding success. Total antibiotic
use was cut by more than 50 per-
cent, and very few health problems
were encountered.
The ban at the weaning stage in
2000 was much more difficult for
farmers; they reported some signifi-
cant health problems, especially in
the early stages of pig production.
Producers responded by restricting
feed for the first two weeks. As
problems of piglet mortality and
disease mounted, veterinarians be-
came more dependent on the use of
therapeutic antibiotics. As a result,
although the use of AGPs fell to
nearly zero in 2000, the use of anti-
biotics as therapeutic medications
increased. Therapeutic medications
were increasingly substituted for
the now-banned AGPs. Thus, the
consumption of total antibiotics in-
creased from 74 mt in 1999 to 81 mt
in 2000 and to 94 mt in 2001. De-
spite this increase, the overall level
of antibiotic use in 2001 was still
limited to about 60 percent of the
level used in 1996 before the ban at
the finishing stage. On a per pig ba-
sis, the level in 2001 was estimated
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(Danish Veterinary Institute 2002).
FIGURE 1. TOTAL CONSUMPTION OF ANTIBIOTICS IN DENMARK
(MT OF ACTIVE INGREDIENTS)
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to be 3.0 grams per pig, down from
earlier levels (DANMAP 2001, Danish
Veterinary Institute, July 2002).
Most of the pig health problems
experienced after the ban were de-
scribed as problems with post-
weaning diarrhea and also some
diarrhea at the finishing stage. The
Danish producers and veterinarians
we spoke with reported that the
pigs were weaker and more vulner-
able to disease when they were
moved to the finishing barns. The
Danish experience suggests that re-
duced use of antibiotics at the
weaning stage has had significant
animal health effects throughout
the production system.
COST IMPACTS AND U.S. ESTIMATES
Based on what we learned in Den-
mark and on an earlier publication
that measured the costs associated
with a previous Swedish ban, we cal-
culated the components of the cost
of the ban. These costs include pre-
weaning costs of $1.25 per animal, a
1.5 percent decrease in post-weaning
feed efficiency, an increase of fatten-
ing-finish mortality of 0.04 percent-
age points, a decrease in sow
productivity by 4.82 percent, an in-
crease in veterinary and therapeutic
costs (net of the AGP cost) of $0.25
per pig, and a $0.75 cost per pig for
new vaccines.
In addition, we included sort-
loss costs of $0.64 per animal be-
cause of increased variability of
weights expected with the move
away from AGPs and the penalty
packers place on the lighter-weight
pigs. We also incorporated capital
costs of $63 million for the addi-
tional space needed for the extra
five days post-weaning, and we in-
cluded $166 million for the addi-
tional sow space.
Our best estimate is that costs
would increase by approximately
$4.50 per animal in the first year. We
estimate the total cost of a ban to
the U.S pork industry spread across
a ten-year period to be in excess of
$700 million. The expected cost to
consumers is an approximate 2 per-
cent increase in retail prices.
The estimated first-year impact
of $4.50 per head due to the effects
of a ban on AGPs represents a pro-
duction cost increase of approxi-
mately 4.5 percent. This cost
increases slightly as more buildings
are required in subsequent years
and there are fewer animals but the
same fixed costs. Comparable esti-
mates of other studies suggest that
the costs are likely to range from
$3.00 to $4.50 per pig.
LIKELY EFFECTS FOR THE U.S. PORK
INDUSTRY
With increased costs and declines in
production, it is likely that some pro-
ducers would be forced out of busi-
ness. However, a lower level of
production increases wholesale and
retail prices, and higher prices help
offset some of the cost increases. The
profit impact is greatest in year one.
By year two, the consumer is paying
for most of the cost increase, and pro-
ducer profits would fall. The end re-
sult is a slightly smaller U.S. pork
industry, as slightly higher retail
prices would lead to lower consump-
tion. The productivity decline associ-
ated with the ban would be recovered
by normal technological advances,
but the dollars lost to individual pro-
ducers during the adjustment phase
would not be recovered.
One important lesson from the
Danish experience is that there is
wide variation in the effects in-
curred among producers. Our re-
sults show the economic impacts of
a ban on an “average” or “represen-
tative” farm. These results mask
wide differences across farms, and
we did not include these distribu-
tional effects in the model.
The Danish experience clearly
illustrates the differences between
the effects of a ban at the weaning
stage and one implemented at the
finishing stage. The Danes achieved
a large reduction in antibiotic use,
and producers encountered few
costs when they banned at the fin-
ishing stage. However, when they
imposed a ban at the weaning stage,
they encountered increased post-
weaning health problems leading to
increased medication and other
costs. In general, the Danes achieved
80 percent of the benefits for 20 per-
cent of the costs when they imposed
a partial ban, and they encountered
20 percent of the benefits and 80
percent of the costs when they ex-
tended the ban.
Faced with similar problems,
U.S. veterinarians would likely resort
to greater use of therapeutic antibi-
otics, and the total use of antibiotics
could rise, much as has happened in
Denmark in the period immediately
after the ban at the weaning stage.
The economic impact of a U.S.
ban largely would depend on the
willingness of U.S. veterinarians to
increase therapeutic use, and the
analysis assumes some increase in
veterinary costs and vaccines. Re-
cent experience in the United King-
dom indicates that the costs and
management of eliminating use of
subtherapeutic antibiotics are sig-
nificant. Under agreements with re-
tailers, U.K. producers eliminated
AGPs in poultry production in 2000.
Now, faced with significant prob-
lems of disease and diarrhea in
their flocks, they are reintroducing
antibiotics to prevent disease. Cur-
rently, total antibiotic use has
dropped, but AGP use may increase
as producers try to manage animal
health concerns.
FOR MORE INFORMATION
See the full report, “Lessons from
the Danish Ban on Feed-Grade Anti-
biotics,” CARD Briefing Paper 03-BP
41, at the CARD website:
<http:\\www. card.iastate.edu.
html?pub_id=84&c=1&synopsis=1>.◆
